CREATE Launches First Human Trial of In Vivo CAR-T Therapy
CAMBRIDGE, Mass., July 30, 2026 CREATE Medicines has received Human Research Ethics Committee (HREC) approval in Australia to initiate...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
CAMBRIDGE, Mass., July 30, 2026 CREATE Medicines has received Human Research Ethics Committee (HREC) approval in Australia to initiate...
RESEARCH TRIANGLE, N.C., July 30, 2026 Basking Biosciences has announced the publication of groundbreaking preclinical research in Communications Biology,...
